Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Shanghai Stock Exchange 600329.SS

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Price to Earnings Ratio (P/E) on January 14, 2025: 19.75

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Price to Earnings Ratio (P/E) is 19.75 on January 14, 2025, a -6.85% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.
  • Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 52-week high Price to Earnings Ratio (P/E) is 25.89 on October 08, 2024, which is 31.09% above the current Price to Earnings Ratio (P/E).
  • Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 52-week low Price to Earnings Ratio (P/E) is 16.57 on February 02, 2024, which is -16.09% below the current Price to Earnings Ratio (P/E).
  • Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited average Price to Earnings Ratio (P/E) for the last 52 weeks is 21.28.
Key data
Date Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield
Market news
Loading...
Shanghai Stock Exchange: 600329.SS

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

CEO Mr. Jian Ma
IPO Date June 6, 2001
Location China
Headquarters Zhong Xin Mansion
Employees 4,619
Sector Health Care
Industries
Description

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and healthcare products primarily in the People's Republic of China. It operates in Chinese Medicine and Western Medicine segments. The company is also involved in the manufacture and sale of Chinese and western pharmaceutical and biological products; wholesale and retail sale of medicines, biochemical pharmaceutical products, and daily use products; and operation of hospitals. In addition, it provides logistics, stocks, equipment installation, and medicine processing services; medicine inspection and testing services; and pharmaceutical consultancy services. The company sells its medicinal products under its own brand to the wholesalers; and purchases medicinal products under other brands from distributors and sells these to other wholesalers. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited was incorporated in 1992 and is based in Tianjin, the People's Republic of China.

Similar companies

600267.SS

Zhejiang Hisun Pharmaceutical Co., Ltd.

USD 1.08

2.47%

600285.SS

Henan Lingrui Pharmaceutical Co., Ltd.

USD 2.90

2.56%

600380.SS

Joincare Pharmaceutical Group Industry Co.,Ltd.

USD 1.47

0.94%

StockViz Staff

January 15, 2025

Any question? Send us an email